Profile data is unavailable for this security.
About the company
Stryker Corporation (Stryker) is a medical technology company. The Company offers products and services in Medical and Surgical, Neurotechnology, Orthopedics and Spine that help improve patient and healthcare outcomes. The Company operates through two segments: MedSurg and Neurotechnology, and Orthopedics and Spine. Its products include surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment and intensive care disposable products; clinical communication and workflow solutions; neurosurgical and neurovascular devices; implants used in joint replacement and trauma surgeries; Mako Robotic-Arm Assisted technology; spinal devices; as well as other products used in a variety of medical specialties. Stryker is also engaged in the design and development of neurointerventional devices for the treatment of intracranial aneurysms. Stryker's geographical segments include the United States and the International.
- Revenue in USD (TTM)20.50bn
- Net income in USD3.17bn
- Incorporated1946
- Employees52.00k
- LocationStryker Corp2825 Airview BlvdKALAMAZOO 49002United StatesUSA
- Phone+1 (269) 389-2600
- Fax+1 (269) 385-1062
- Websitehttps://www.stryker.com/
More ▼
Mergers & acquisitions
| Acquired company | SYK:NYQ since announced | Transaction value |
|---|---|---|
| Serf SAS | 12.86% | -- |
Data delayed at least 15 minutes, as of Apr 18 2024 21:10 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Resmed Inc | 4.50bn | 890.39m | 26.12bn | 10.14k | 29.42 | 5.83 | 24.39 | 5.80 | 6.04 | 6.04 | 30.53 | 30.47 | 0.6633 | 2.10 | 6.17 | 444,189.10 | 13.11 | 13.59 | 14.74 | 15.89 | 55.11 | 56.98 | 19.77 | 19.22 | 1.89 | 19.64 | 0.2149 | 36.66 | 18.02 | 12.53 | 15.15 | 14.63 | 13.40 | 4.68 |
| West Pharmaceutical Services Inc. | 2.95bn | 593.40m | 27.62bn | 10.60k | 47.87 | 9.63 | 38.74 | 9.36 | 7.88 | 7.88 | 39.19 | 39.20 | 0.7923 | 4.29 | 5.79 | 278,283.00 | 15.46 | 15.61 | 18.41 | 18.65 | 38.28 | 38.06 | 19.52 | 18.47 | 2.24 | -- | 0.067 | 10.69 | 2.18 | 11.43 | 2.28 | 23.76 | 28.16 | 6.20 |
| GE HealthCare Technologies Inc | 19.55bn | 1.39bn | 38.77bn | 51.00k | 27.99 | 5.42 | 18.96 | 1.98 | 3.04 | 3.03 | 42.77 | 15.67 | 0.6518 | 5.65 | 4.44 | 383,372.60 | 5.39 | -- | 7.45 | -- | 40.52 | -- | 8.28 | -- | 0.8295 | 5.43 | 0.5636 | -- | 6.60 | -- | -26.82 | -- | -- | -- |
| DexCom Inc | 3.62bn | 541.50m | 51.77bn | 9.60k | 104.76 | 25.02 | 71.17 | 14.29 | 1.28 | 1.28 | 8.55 | 5.37 | 0.6215 | 3.04 | 4.29 | 377,322.90 | 9.29 | 8.30 | 13.11 | 10.50 | 63.65 | 65.90 | 14.95 | 14.14 | 2.48 | -- | 0.5465 | 0.00 | 24.49 | 28.56 | 58.70 | -- | 28.66 | -- |
| Edwards Lifesciences Corp | 6.00bn | 1.40bn | 52.04bn | 19.80k | 37.56 | 7.81 | 33.70 | 8.67 | 2.30 | 2.30 | 9.85 | 11.06 | 0.6802 | 1.35 | 8.47 | 303,272.70 | 15.85 | 16.63 | 18.21 | 19.12 | 77.02 | 76.71 | 23.30 | 24.84 | 2.40 | -- | 0.0816 | 0.00 | 11.56 | 10.03 | -7.85 | 13.70 | 1.96 | -- |
| Becton Dickinson and Co | 19.49bn | 1.27bn | 67.36bn | 73.00k | 53.21 | 2.66 | 18.99 | 3.46 | 4.38 | 4.23 | 67.25 | 87.68 | 0.3699 | 3.31 | 8.57 | 267,013.70 | 2.47 | 2.37 | 2.89 | 2.70 | 41.37 | 45.78 | 6.68 | 6.95 | 0.6435 | 6.45 | 0.3887 | 81.23 | 2.66 | 3.92 | -4.85 | 12.97 | -0.4737 | 3.94 |
| Boston Scientific Corporation | 14.24bn | 1.57bn | 99.10bn | 48.00k | 62.95 | 5.12 | 35.83 | 6.96 | 1.07 | 1.07 | 9.73 | 13.16 | 0.4213 | 1.99 | 6.78 | 296,666.70 | 4.71 | 2.50 | 5.43 | 2.91 | 69.65 | 68.84 | 11.18 | 6.47 | 0.8170 | 5.16 | 0.3179 | 0.00 | 12.29 | 7.71 | 144.55 | -0.4276 | 7.82 | -- |
| Medtronic PLC | 32.32bn | 4.20bn | 105.15bn | 95.00k | 25.11 | 2.03 | 15.23 | 3.25 | 3.15 | 3.15 | 24.27 | 38.95 | 0.3495 | 2.00 | 5.45 | 340,210.50 | 4.58 | 4.78 | 5.28 | 5.37 | 65.73 | 67.68 | 13.10 | 14.28 | 1.71 | 30.78 | 0.3263 | 72.49 | -1.45 | 0.8366 | -25.42 | -6.95 | 6.44 | 8.13 |
| Stryker Corp | 20.50bn | 3.17bn | 124.58bn | 52.00k | 39.70 | 6.69 | 29.71 | 6.08 | 8.25 | 8.25 | 53.42 | 48.92 | 0.5338 | 1.67 | 5.59 | 394,192.30 | 8.24 | 6.60 | 10.12 | 7.84 | 63.90 | 63.99 | 15.44 | 13.13 | 0.9689 | -- | 0.4114 | 43.70 | 11.11 | 8.55 | 34.22 | 9.68 | 0.1047 | 10.16 |
| Intuitive Surgical, Inc. | 7.12bn | 1.80bn | 132.08bn | 13.68k | 74.11 | 9.86 | 58.13 | 18.54 | 5.03 | 5.03 | 19.93 | 37.77 | 0.5014 | 2.27 | 6.88 | 520,919.90 | 12.79 | 12.42 | 14.44 | 13.83 | 66.39 | 67.60 | 25.51 | 26.31 | 4.02 | -- | 0.00 | 0.00 | 14.49 | 13.85 | 35.98 | 9.77 | 41.53 | -- |
| Abbott Laboratories | 40.33bn | 5.63bn | 182.66bn | 114.00k | 32.69 | -- | 21.39 | 4.53 | 3.22 | 3.22 | 23.06 | -- | -- | -- | -- | 353,736.80 | -- | 7.72 | -- | 9.39 | 55.22 | 56.73 | 13.96 | 14.39 | -- | 22.58 | -- | 54.95 | -8.12 | 5.58 | -17.45 | 18.36 | 9.57 | 12.74 |
| Thermo Fisher Scientific Inc | 42.86bn | 6.00bn | 206.71bn | 122.00k | 35.05 | 4.48 | 21.94 | 4.82 | 15.45 | 15.45 | 110.46 | 120.87 | 0.4376 | 4.80 | 4.49 | 351,286.90 | 6.14 | 7.79 | 7.31 | 9.11 | 39.90 | 44.94 | 14.03 | 16.76 | 1.39 | 13.56 | 0.4271 | 6.75 | -4.58 | 11.96 | -13.74 | 14.43 | 14.30 | 15.39 |
Data as of Apr 18 2024. Currency figures normalised to Stryker Corp's reporting currency: US Dollar USD
35.58%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2023 | 29.69m | 7.81% |
| Greenleaf Asset Management, Inc.as of 05 Feb 2024 | 21.05m | 5.54% |
| BlackRock Fund Advisorsas of 31 Dec 2023 | 16.12m | 4.24% |
| SSgA Funds Management, Inc.as of 31 Dec 2023 | 14.27m | 3.75% |
| Wellington Management Co. LLPas of 31 Dec 2023 | 12.16m | 3.20% |
| T. Rowe Price Associates, Inc. (Investment Management)as of 31 Dec 2023 | 12.08m | 3.18% |
| Capital Research & Management Co. (Global Investors)as of 31 Dec 2023 | 10.21m | 2.68% |
| Fundsmith LLPas of 31 Dec 2023 | 7.28m | 1.91% |
| Geode Capital Management LLCas of 31 Dec 2023 | 6.39m | 1.68% |
| Wellington Management International Ltd.as of 31 Dec 2023 | 6.06m | 1.60% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
